Join your colleagues and peers in clinical research and immuno-oncology to discuss breakthroughs in the fight against cancer. This April, you can help to shape the figure of precision medicine.

Scientists have developed a new process to generate nucleus pulposus-like cells from human induced pluripotent stem cells, which mimics the process of embryonic development.

This first application of these measures in patients living with MS could lead to new ways to monitor the effectiveness of drug treatment and physical therapy in slowing or stopping the progression of this chronic and often debilitating disease.

High levels of the protein ZMYND8 are correlated with poor survival in breast cancer patients.

A new blood test using gold nanoparticles could soon give oncologists an early and more accurate prognosis of how cancer treatment is progressing and help guide the ongoing therapy of patients.

Novel stem cell technology will be used to grow the massive number of stem cells required for a new hand-held 3D printer that will enable surgeons to create patient-specific bone and cartilage.

The fungus, Amanita phalloides, produces one of the world's deadliest toxins. While it may seem ill-advised, researchers are eager to synthesize the toxin because studies have shown that it could help fight cancer.